OpenAI launches biodefense program to enhance pandemic preparedness

The closest the field has come to solving the planar unit distance problem, first proposed in the 1940s, was in 1984. Now, OpenAI claims an internal model has cracked the puzzle.

Ohio's tax break suspension highlights the need for states to balance tech investment incentives with sustainable fiscal and energy policies. The post Ohio suspends data center tax break amid AI power cost debate appeared first on Crypto Briefing.

When newly public companies have been valued as richly as SpaceX, OpenAI and Anthropic seem likely to be, the outlook for ordinary investors has been poor.

Pope Leo XIV may not be able to disarm AI, but he’s got the attention of the industry.

Government and industry experts say by placing governance and security controls around data will help make implementing AI tools easier in the end.

Snowflake's AI-driven revenue growth and increased customer commitment signal strong market positioning, despite competition from major cloud providers. The post HSBC upgrades Snowflake to Buy, sets price target at $289 appeared first on Crypto Briefing.

The strongest AI voices are not just people with impressive job titles. They are researchers pushing the technical boundaries of AI. Founders building AI communities. Practitioners turning models into products. Even leaders, helping businesses understand what this technology can actually do. This becomes even more important when we look at India’s growing role in the […] The post 25 Most Influential AI Pioneers to Meet at DataHack Summit 2026 appeared first on Analytics Vidhya.

The post OpenAI biodefense program targets pandemic preparedness appeared on BitcoinEthereumNews.com. A new OpenAI biodefense program is pushing the company deeper into one of AI’s most sensitive frontiers: pandemic preparedness. The move is not just about building models. It combines startup investing, policy engagement, and safety systems aimed at spotting biological threats before they turn into wider crises. That strategy has been taking shape for months. In July 2025, OpenAI brought together government entities, NGOs, and researchers for a biodefense summit focused on countermeasures and dual-use risks. Then, within weeks later that year, it backed two startups working on biological risk detection and mitigation. The pattern matters because it shows OpenAI treating biosecurity less like a side research topic and more like an emerging operating priority. At a time when AI’s role in life sciences is expanding fast, the company appears to be building a position that spans tools, part